The global blood pressure management supplement market is projected to grow at a compound annual growth rate (CAGR) of 4.1%, from a valuation of US$ 29.3 billion in 2024 to US$ 43.7 billion by the end of 2034. Over time, there has been a consistent rise in the sales of supplements designed to control blood pressure in tandem with an increase in the prevalence of conditions like...